🇺🇸 FDA
Pipeline program

PREDNISONE

Approved small_molecule active

Quick answer

PREDNISONE for Idiopathic retroperitoneal fibrosis is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Idiopathic retroperitoneal fibrosis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials